Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/28647| Title: | Combination Tofacitinib and Calcineurin Inhibitor in the Management of Treatment-Refractory Ulcerative Colitis May Be Effective, But Is It Necessary? | Austin Authors: | Peterson, Adam R;Hilley, Patrick ;De Cruz, Peter P | Affiliation: | Medicine (University of Melbourne).. Gastroenterology and Hepatology.. |
Issue Date: | 30-Mar-2022 | Date: | 2022 | Publication information: | Inflammatory bowel diseases 2022; 28(4): e46 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/28647 | DOI: | 10.1093/ibd/izab356 | ORCID: | 0000-0002-9398-965X | Journal: | Inflammatory bowel diseases | PubMed URL: | 35045169 | PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/35045169/ | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.